SK

Suresh Kumar

Active Director Director DIN 10702462
DIN 10702462 First appointment Jul 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value •••• Premium profile

About Suresh Kumar

Data last updated:

Suresh Kumar is a Director at United Bioceuticals Private Limited (since 2024). The company operates in Pharma. United Bioceuticals Private Limited reported revenue of ₹67.35 Cr (FY 2024).

DIN 10702462
Primary Designation Director
Industry Pharma
First Appointment 11 Jul 2024
Oldest Company Age 9 yrs
Largest company United Bioceuticals Private Limited · ₹67.35 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
United Bioceuticals Private Limited U33100DL2017PTC325675
Director11 Jul 20242017₹67.35 Cr (FY 2024)Active

Board colleagues of Suresh Kumar

Directorship timeline

Open interactive timeline →
United Bioceuticals Private Limited
Premium access

Shareholding and investment profile for Suresh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Kumar

Suresh Kumar currently holds 1 directorship: United Bioceuticals Private Limited (Director, since 11 Jul 2024, revenue ₹67.35 Cr (FY 2024)).

Suresh Kumar was first appointed on 11 Jul 2024 as Director at United Bioceuticals Private Limited.

The current boards of Suresh Kumar's companies include Deepak Juneja (United Bioceuticals Private Limited), Hukam Chand Sharma (United Bioceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available